###### Strengths and limitations of this study

-   Shelter stay was associated with higher risk for seroconversion of *Entamoeba histolytica*.

-   Amoebiasis was more evident among displaced persons staying in shelters.

-   Data from two rounds of examinations were available for all 288 displaced persons.

-   No direct examination of drinking water in the shelters was carried out.

Introduction {#s1}
============

Climate change, resulting from an imbalance between radiation entering and exiting the atmosphere, is thought to alter the hydrological cycle.[@R1] In the past few decades, climate change and global warming have been suggested as the triggers for increased severity of cyclones, flooding[@R2] and major hurricane-related damage, even in temperate regions.[@R3] Flooding, which is the most common type of disaster globally,[@R4] has significantly impacted places such as Hunan, China, where river flooding has caused an increase in mortality rates as well as potential years of lost life.[@R5]

Natural disasters such as typhoons, cyclones, earthquakes, tsunamis or flooding are also associated with an increased incidence of vector-borne and water-borne infectious diseases.[@R1] [@R6] [@R7] Indeed, a number of reports have suggested that large-scale cyclones with extensive flooding impose a burden on the public health system[@R8] due to outbreaks of infectious diseases such as cholera, typhoid fever, acute hepatitis A, leptospirosis, melioidosis, measles, dengue fever, malaria and amoebiasis.[@R9] An important contributory factor for such disease outbreaks may be the displacement of large numbers of people from their homes into over-crowded shelters where supplies may be limited.[@R9] The availability and accessibility of medical services after such natural disasters is also a major concern.[@R14] Epidemiological studies have reported that the increased incidence of infectious diseases after such disasters is associated with environmental changes, crowded shelter conditions and an inadequate or dirty water supply.[@R9] Risk behaviours linked to sexually transmitted diseases also may increase after a disaster as a result of the unaccompanied status of primary sex partners.[@R15]

Typhoon Morakot struck southern Taiwan between 7 and 9 August 2009, with massive rainfall (\>1000 mm) and flooding, resulting in 673 deaths and property losses of more than 19 billion New Taiwan Dollars. In contrast to tsunamis, where flooding occurs along coastal areas, the major rainfall and flooding during Typhoon Morakot occurred along coastal areas as well as inland areas. Southern Taiwan had the most severe damage in mountainous and coastal areas.[@R16] Thousands of Taiwanese citizens were displaced from their original residences in coastal, plains and mountainous areas, and moved to shelters or to urban communities. This movement made the collection and accuracy of medical records unreliable. Owing to these challenges, no longitudinal population-based surveys were conducted either during or after Typhoon Morakot to examine the occurrence of infectious diseases among displaced people. It is also not clear which post-disaster shelter policies should be examined with caution when drafting guidelines for prevention of infectious diseases.

In order for government agencies to prepare more effectively for post-disaster management, it is important: (1) to understand differences between disaster-displaced persons staying in shelters and those remaining in the community, and (2) to collect adequate and accurate population-based serological epidemiological evidence of infectious diseases after such disasters.

In this longitudinal study, we performed serological testing to track communicable diseases in two groups of people displaced from their homes: those who were moved to shelters, and those who remained in the community. The major aims of this study were: (1) to investigate the serological status of vaccine-preventable droplet-borne and water-borne infectious diseases in displaced persons staying in shelters, and those in the community, and (2) to identify risk factors associated with seroconversion of infectious diseases.

Materials and methods {#s2}
=====================

This longitudinal epidemiological survey of 288 adult flood-displaced persons was conducted between December 2009 and July 2010, during the post-flood period 4--11 months after Typhoon Morakot in Taiwan. People living in the mountainous areas who were moved for longer than 2 weeks into shelters equipped with beds and a water supply were categorised as the shelter group. Those who had lived in a shelter for less than 2 weeks were excluded from further analysis. In contrast, storm-displaced persons who did not move into shelters, but went to live with their families in urban areas, were categorised as the community group. All 288 cases were from the Kaohsiung County. Hepatitis A vaccination was provided to those people who lived in the mountainous areas for several years before this typhoon.[@R17] The Institutional Review Board of Kaohsiung Medical University Hospital reviewed and approved the study protocol, and all participants provided written informed consent. People younger than 20 years old were excluded from the study.

Study design {#s2a}
------------

We sampled the first serum specimens between December 2009 and January 2010, 4--5 months after the typhoon. We performed second-round testing after 6 months. At the first and second sampling, each participant was asked to complete a structured questionnaire, either individually or with the help of trained staff during a face-to-face interview. The first questionnaire (for first sampling) included epidemiological data, underlying diseases and severity of trauma during the typhoon (family member\'s death or major trauma). The second questionnaire (for second sampling) included duration of shelter stay before returning to one\'s original residence.

First-round sampling {#s2b}
--------------------

The first-round specimens were analysed for biochemistry data and nutritional status. Serological tests included IgG levels for vaccine-preventable diseases (measles, mumps and rubella, which all require mandatory notification), *E. histolytica* serological titres (IgG using IHA (indirect haemagglutination)) and IgM/IgG for leptospirosis. We also measured IgG levels of herpes simplex virus (HSV)-1, HSV-2 and Venereal Disease Research Laboratory, for syphilis. Amoebiasis (IHA), HSV-1 and HSV-2 tests were performed by the College of American Pathologists (CAP) Accreditation Programmes Laboratory. All other tests were performed in our own laboratory, which is a Biosafety level-2 (BSL-2) certified lab.

[Table 1](#BMJOPEN2014007008TB1){ref-type="table"} lists the details of the serological test kits used in the present study. Patients with positive syphilis screening results were contacted between first-round and second-round specimen collection, their serum was reanalysed and they were provided adequate treatment. No scheduled vaccination programme was provided to the shelter group or to the community group between the two samplings, except for vaccination for the 2009 pandemic H1N1 influenza strain.[@R18]

###### 

Serological test kits used in the present study

  Disease            Products                                       Manufacturer          City            Country
  ------------------ ---------------------------------------------- --------------------- --------------- ---------
  Measles            Measles virus IgG--ELISA                       NovaLisa              Dietzenbach     Germany
  Mumps              Mumps virus IgG--ELISA                         NovaLisa              Dietzenbach     Germany
  Rubella            Rubella virus IgG--ELISA                       NovaLisa              Dietzenbach     Germany
  Amoebiasis (IHA)   Cellognost--Amoebiasis                         Behring Diagnostics   Marburg         Germany
  Leptospirosis      *OnSite* Leptospira IgG/IgM Combo Rapid Test   CTK Biotech, Inc      San Diego, CA   USA
  HSV-1              Anti-HSV-1 ELISA (IgG)                         Euroimmun             Lübeck          Germany
  HSV-2              Anti-HSV-2 ELISA (IgG)                         Euroimmun             Lübeck          Germany
  VDRL of syphilis   Syphilis RPR Test                              Human                 Wiesbaden       Germany

HSV, herpes simplex virus; RPR, rapid plasma reagin; VDRL, Venereal Disease Research Laboratory.

Second-round sampling {#s2c}
---------------------

Six months after the first sampling, a second-round serum sampling was conducted to evaluate for measles, mumps, rubella and *E. histolytica*, using the same methods. If a participant had negative results for measles, mumps and/or rubella in the first round, and positive results in the second, we defined this as an IgG seroconversion. (If a participant had positive results for measles, mumps and/or rubella in the first-round already, he or she did not receive recheck of measles, mumps and/or rubella IgG in the second-round). The cut-off value of positive results of the IHA test for amoebiasis was previously established as ≥1:128.[@R19] [@R20] However, there is evidence that this cut-off value may miss some cases with parasitologically positive amoebiasis.[@R21] [@R22] Therefore, with two blood samples collected at an interval of at least 16 weeks, we defined IgG seroconversion for amoebiasis as ≥1:64 at the second sampling as well as a fourfold titre increase when compared to first sampling results, which indicates recent infection.[@R23]

Follow-up telephone interview {#s2d}
-----------------------------

Telephone interviews were conducted for all displaced persons with IHA seroconversion within 1 month after the second sampling. The structured questionnaire that was used mainly inquired about gastrointestinal symptoms and signs of amoebiasis, including diarrhoea, abdominal pain and dysentery.

Statistical analysis {#s2e}
--------------------

Data were summarised as n (%) for categorical variables, mean±SD for continuous variables and median (IQR: Q1, Q3) for continuous variables with non-normal distribution. Between-group differences in categorical data were compared by Pearson χ^2^ test or Fisher\'s exact test if case numbers were less than five. Between-group differences in continuous data were compared by two-sample t test and by Mann-Whitney U test if data were without normal distribution. Associations between seroconversion among shelter stay, participants' demographics, medical history and laboratory data were further identified. Variables significantly associated with seroconversion were placed into univariate and multivariate logistic regression analysis. Results were presented as ORs and corresponding 95% CIs of OR (95% CI) and p values. All statistical assessments were two-tailed and p\<0.05 represented statistical significance. All analyses were conducted using SPSS statistical software V.18.0 (SPSS Inc, Chicago, Illinois, USA).

Results {#s3}
=======

Demographic characteristics and laboratory data {#s3a}
-----------------------------------------------

A total of 288 participants (96 males/192 females) with complete follow-up data through two rounds of sampling were enrolled into evaluation. The average age was 58.42 years (SD=12.73) with a range of 31 to 87 years. [Table 2](#BMJOPEN2014007008TB2){ref-type="table"} summarises the demographics, medical history and laboratory data of participants in the shelter group, and those in the community group. There was no significant difference in the distribution of demographics and medical histories between the two groups (all p\>0.05). Although there was a difference in age between the shelter and community groups, this difference was of borderline significance (median (IQR): 55 (48, 66) vs 57 (50, 70), p=0.049). The second round of testing showed that participants placed in shelters had significantly higher levels of serum glutamic pyruvate transaminase (GPT values; serum GPT \>40 IU/L) as well as significantly lower total cholesterol values than those in the community (serum GPT: 28.9% vs 13.2%, p=0.001; total cholesterol: 188.65±38.33 mg/dL vs 199.15±42.40 mg/dL, p=0.034; [table 2](#BMJOPEN2014007008TB2){ref-type="table"}). Comparison of first-round and second-round data showed that participants in shelters had significantly higher levels of serum GPT, but significantly lower levels of serum albumin and total cholesterol than participants in the community (all p\<0.05).

###### 

Participants' demographics, medical history and laboratory data by group (N=288)

  ------------------------------------------------------------------------------------------------------------------------
  Variables                               Total\               Shelter group\           Community group\         p Value
                                          (n=288)              (n=114)                  (n=174)                  
  --------------------------------------- -------------------- ------------------------ ------------------------ ---------
  Demographics                                                                                                   

   Gender, male (%)                       96 (33.3)            37 (32.5)                59 (33.9)                0.798

   Age ≥65 years, n (%)                   94 (32.6)            30 (26.3)                64 (36.8)                0.064

   BMI                                    28.20±4.92           28.60±4.67               27.94±5.08               0.268

   Ratio of waist and hip                 0.90±0.07            0.89±0.07                0.90±0.07                0.266

  Education                                                                                                      0.913

   Junior high school or lower            159 (55.2%)          64 (56.1%)               95 (54.6%)               

   High school and college                54 (18.8%)           20 (17.5%)               34 (19.5%)               

   Without formal education and unknown   75 (26.0%)           30 (26.3%)               45 (25.9%)               

   Single¶, n (%)                         121 (42.0)           46 (40.4)                75 (43.1)                0.643

   Family with major trauma               10 (3.5)             6 (5.3)                  4 (2.3)                  0.201

  Medical history                                                                                                

   Hypertension                           127 (46.2)           53 (47.3)                74 (45.4)                0.753

   Diabetes mellitus                      45 (16.4)            20 (17.9)                25 (15.3)                0.579

   Hyperlipidaemia                        177 (61.5)           20 (17.9)                111 (63.8)               0.315

   Hyperuricaemia                         91 (31.6)            33 (28.9)                58 (33.3)                0.434

   Ischaemic heart disease                10 (3.6)             5 (4.5)                  5 (3.1)                  0.543

   Gouty arthritis                        35 (12.7)            19 (17.0)                16 (9.8)                 0.081

   Cerebrovascular disease                6 (2.2)              1 (0.9)                  5 (3.1)                  0.406

  Laboratory data                                                                                                

  After typhoon (first round)                                                                                    

   SERUM GPT \>40 IU/L                    49 (17.0)            23 (20.2)                26 (14.9)                0.248

   Creatinine \>1.5 mg/dL                 22 (7.6)             8 (7.0)                  14 (8.0)                 0.748

   Serum albumin, mg/dL                   4.40 (4.30, 4.60)    4.40 (4.30, 4.60)        4.40 (4.20, 4.60)        0.227

   Total cholesterol, mg/dL               203.98±46.34         197.85±37.00             208.00±51.26             0.084

   Triglyceride, mg/dL                    150 (92, 233.25)     142 (89.75, 219.25)      155.50 (92.00, 242.75)   0.111

  Follow-up (second round)                                                                                       

   SERUM GPT\>40 IU/L                     56 (19.4)            33 (28.9)‡               23 (13.2)                0.001\*

   Creatinine \>1.5 mg/dL                 20 (6.9)             6 (5.3)                  14 (8.0)                 0.364

   Serum albumin, mg/dL                   4.30 (4.20, 4.50)†   4.30 (4.20, 4.50)‡       4.30 (4.18, 4.50)§       0.447

   Total cholesterol, mg/dL               194.99±41.09†        188.65±38.33‡            199.15±42.40§            0.034\*

   Triglyceride, mg/dL                    150 (102, 257.50)†   142.50 (98.25, 208.75)   156.50 (102, 275)§       0.240
  ------------------------------------------------------------------------------------------------------------------------

Data are summarised as n (%) for categorical variables, mean±SD for continuous variables and median (IQR: Q1, Q3) for continuous variables without normal distribution.

Differences between shelter and community groups in categorical data were compared using Pearson χ^2^ test or Fisher\'s exact test if there were any cases numbering less than five; for continuous data, differences between shelter group and community group were compared using two-sample t test, and Mann-Whitney U test, in data without normal distribution.

\*p\<0.05, indicates significant differences between shelter and community groups.

†‡§P\<0.05, indicates significant differences when comparing data after typhoon in †total, ‡shelter group and §community group, separately.

¶Including divorced or unmarried participants, or widows or widowers.

BMI, body mass index.

First-round serology results {#s3b}
----------------------------

[Table 3](#BMJOPEN2014007008TB3){ref-type="table"} summarises the first round of serology tests. First round testing after the typhoon showed that participants in shelters had a significantly higher rate of mumps, but a significantly lower rate of HSV-2, compared to the community group (mumps: 81.6% vs 69.5%, p=0.022; HSV-2: 27.2% vs 40.2%, p=0.023). All 288 participants in the first round examination were subjected to a second round of testing after 6 months. There were no significant differences in the incidence of vaccine-preventable diseases or in water-borne diseases between participants in shelters and in community (all p\>0.05). There was one case of measles seroconversion, 3 cases of mumps seroconversion and 10 cases of rubella seroconversion, in all. Of the 288 participants, 128 participants (44.4%) showed amoebiasis seroconversion by the IHA test. The rate of amoebiasis seroconversion was higher among participants who had stayed in shelters 2 weeks or more compared to those who remained in the community (56.1% vs 36.8%; p=0.001; [table 3](#BMJOPEN2014007008TB3){ref-type="table"}).

###### 

Positive results after the typhoon and during follow-up (N=288)

  Variables                                                                          Total (n=288)   Shelter group (n=114)   Community group (n=174)   p Value
  ---------------------------------------------------------------------------------- --------------- ----------------------- ------------------------- ---------
  *After typhoon (first round)*                                                                                                                        
  Vaccine-preventable diseases                                                                                                                         
   Measles                                                                           261 (90.6)      102 (89.5)              159 (91.4)                0.587
   Mumps                                                                             214 (74.3)      93 (81.6)               121 (69.5)                0.022\*
   Rubella                                                                           230 (79.9)      91 (79.9)               139 (79.9)                0.990
  Water-borne diseases                                                                                                                                 
   Amoebiasis test \<1:16                                                            89 (30.9)       41 (36.0)               48 (27.6)                 0.132
   Leptospirosis                                                                     2 (2 (0.7)      0 (0)                   2 (1.1)                   NA
  Miscellaneous                                                                                                                                        
   HSV-1                                                                             245 (85.1)      96 (84.2)               149 (85.6)                0.741
   HSV-2                                                                             101 (35.1)      31 (27.2)               70 (40.2)                 0.023\*
   VDRL for syphilis                                                                 2 (0.7)         1 (0.9)                 1 (0.6)                   1.000
  *Follow-up with seroconversion in second round (n for negative in first round)*†                                                                     
   Vaccine-preventable diseases                                                                                                                        
   Measles seroconversion (n=27)                                                     1 (3.7)         1 (8.3)                 0 (0)                     NA
   Mumps seroconversion (n=74)                                                       3 (4.1)         2 (9.5)                 1 (1.9)                   0.192
   Rubella seroconversion (n=58)                                                     10 (17.2)       5 (21.7)                5 (14.3)                  0.496
  Water-borne diseases                                                                                                                                 
   Amoebiasis test \<1:16                                                            21 (23.6)       9 (22.0)                12 (25.0)                 0.806
   Leptospirosis (n=286)                                                             0 (0)           0 (0)                   0 (0)                     NA
  Miscellaneous                                                                                                                                        
   HSV-1 (n=43)                                                                      6 (13.9)        3 (16.7)                3 (12)                    0.683
   HSV-2 (n=187)                                                                     3 (1.6)         2 (2.4)                 1 (1.0)                   0.585
   VDRL for syphilis (n=286)                                                         0 (0)           0 (0)                   0 (0)                     NA
  With amoebiasis (IHA) seroconversion                                                                                                                 0.001\*
   Yes                                                                               128 (44.4)      64 (56.1)               64 (36.8)                 
   No                                                                                160 (55.6)      50 (43.9)               110 (63.2)                

Data are presented as n (%) by accommodations (shelter vs community), and compared using Pearson χ^2^ test or Fisher\'s exact test if any cells number less than five.

\*p\<0.05 indicates significant difference between shelter and community groups.

†Second round testing was carried out for those participants who had negative results after the first round of testing.

HSV, herpes simplex virus; VDRL, Venereal Disease Research Laboratory.

Associations between amoebiasis seroconversion and shelter stay, participants' demographics, medical history and laboratory data, are summarised in [table 4](#BMJOPEN2014007008TB4){ref-type="table"}. Amoebiasis seroconversion was significantly associated with shelter stay and medical history, including hypertension and hyperlipidaemia (all p values\<0.05; [table 4](#BMJOPEN2014007008TB4){ref-type="table"}). The length of stay in the shelter was positively and significantly associated with the rate of seroconversion ([figure 1](#BMJOPEN2014007008F1){ref-type="fig"}).

###### 

Associations between accommodations, participants' demographics, medical history, laboratory data and seroconversion (N=288)

  -----------------------------------------------------------------------------------------------------
  Variables                               Seroconversion\           Without seroconversion\   p Value
                                          (n=128)                   (n=160)                   
  --------------------------------------- ------------------------- ------------------------- ---------
  Accommodations                                                                              0.001\*

   Community                              64 (36.8)                 110 (63.2)                

   Shelter                                64 (56.1)                 50 (43.9)                 

  Demographics                                                                                

  Gender                                                                                      0.933

   Males                                  43 (44.8)                 53 (55.2)                 

   Females                                85 (44.3)                 107 (55.7)                

  Age ≥65 years                                                                               0.955

   No                                     86 (44.3)                 108 (55.7)                

   Yes                                    42 (44.7)                 52 (55.3)                 

  Age, yrs                                59.02±12.33               57.94±13.05               0.475

  BMI, kg/m^2^                            28.29±4.81                28.13±5.02                0.788

  Ratio of waist and hip                  0.90±0.07                 0.89±0.07                 0.491

  Education                                                                                   0.919

   Junior high school or lower            69 (43.4)                 90 (56.6)                 

   High school and college                25 (46.3)                 29 (53.7)                 

   Without formal education and unknown   34 (45.3)                 41 (54.7)                 

  Single†, n (%)                                                                              0.364

   No                                     78 (46.7)                 89 (53.3)                 

   Yes                                    50 (41.3)                 71 (58.7)                 

  Family with major trauma                                                                    0.348

   No                                     122 (43.9)                156 (56.1)                

   Yes                                    6 (60.0)                  4 (40.0)                  

  Medical history                                                                             

   Hypertension                           66 (52.0)                 61 (48.0)                 0.044\*

   Diabetes mellitus                      24 (53.3)                 21 (46.7)                 0.246

   Hyperlipidaemia                        70 (39.5)                 107 (60.5)                0.035\*

   Hyperuricaemia                         44 (48.4)                 47 (51.6)                 0.436

   Ischaemic heart disease                3 (30.0)                  7 (70.0)                  0.246

   Gouty arthritis                        16 (45.7)                 19 (54.3)                 0.974

   Cerebrovascular disease                3 (50.0)                  3 (50.0)                  1.000

  Laboratory data                                                                             

  Pretest                                                                                     

   Serum GPT \>40 IU/L                    23 (46.9)                 26 (53.1)                 0.700

   Creatinine \>1.5 mg/dL                 7 (31.8)                  15 (68.2)                 0.215

   Serum albumin, mg/dL                   4.40 (4.30, 4.60)         4.40 (4.30, 4.60)         0.302

   Total cholesterol, mg/dL               200.16±36.32              207.04±52.93              0.194

   Triglyceride, mg/dL                    148.50 (84.00, 202.50)    160.50 (95.30, 261.00)    0.167

  Follow-up                                                                                   

   Serum GPT \>40 IU/L                    29 (51.8)                 27 (48.2)                 0.218

   Creatinine \>1.5 mg/dL                 7 (35.0)                  13 (65.0)                 0.378

   Serum albumin, mg/dL                   4.30 (4.10, 4.40)         4.30 (4.20, 4.50)         0.087

   Total cholesterol, mg/dL               191.74±39.90              197.59±41.96              0.230

   Triglyceride, mg/dL                    193.00 (162.00, 214.75)   156.50 (106.00, 261.00)   0.248
  -----------------------------------------------------------------------------------------------------

Data are summarised as n (%) for categorical variables, mean±SD for continuous variables, and median (IQR: Q1, Q3) for continuous variables without normal distribution.

Differences between participants with and without seroconversion in categorical data were compared using Pearson χ^2^ test or Fisher\'s exact test if there were any cells numbering less than five; for continuous data, differences between participants with and without seroconversion were compared using two-sample t test and Mann-Whitney U test in data without normal distribution.

\*p\<0.05, indicates significant differences between participants with and without seroconversion.

†Including divorced or unmarried participants, or widows or widowers.

BMI, body mass index.

![Amoebiasis indirect haemagglutination (IHA) seroconversion rate in groups with different lengths of stay in the shelters.](bmjopen2014007008f01){#BMJOPEN2014007008F1}

[Table 5](#BMJOPEN2014007008TB5){ref-type="table"} represents the results of binary logistic regression analysis. Variables that were significantly associated with amoebiasis seroconversion ([table 4](#BMJOPEN2014007008TB4){ref-type="table"}) were placed into univariate and multivariate logistic regression analysis. Univariate analysis showed that shelter stay and hypertension were significantly associated with amoebiasis seroconversion. Paticipants with hyperlipidaemia may be at lower risk for seroconversion (all p\<0.05). After adjusting for medical history, hypertension and hyperlipidaemia, multivariate logistic regression analysis showed that participants who stayed in shelters had a higher risk for seroconversion than those in community. (OR=2.055, 95% CI 1.251 to 3.374; p=0.004; [table 5](#BMJOPEN2014007008TB5){ref-type="table"}).

###### 

Univariate and multivariate logistic regression models analysis of seroconversion (N=288)

                              Univariate                         Multivariate             
  --------------------------- ------------------------ --------- ------------------------ ---------
  Shelter admission                                                                       
   Shelter versus community   2.200 (1.359 to 3.561)   0.001\*   2.055 (1.251 to 3.374)   0.004\*
  Medical history                                                                         
   Hypertension               1.632 (1.011 to 2.635)   0.045\*   1.576 (0.964 to 2.575)   0.070
   Hyperlipidaemia            0.598 (0.370 to 0.965)   0.035\*   0.642 (0.389 to 1.060)   0.083

Results are presented as OR and corresponding 95% CIs of OR (95% CI) and p values.

\*Indicates significance (p\<0.05).

†Variables with significant association with seroconversion were selected into models.

Clinical manifestation of amoebiasis seroconversion {#s3c}
---------------------------------------------------

We retrospectively interviewed 60 seroconverted participants in order to evaluate disease severity. Only 3 (5%) of these patients reported acute diarrhoea (less than 14 days) without dysentery.

Discussion {#s4}
==========

This longitudinal study, which was conducted after Typhoon Morakot and the accompanying flooding, showed that *E. histolytica* seroconversion rates were higher in persons displaced to shelters compared to those remaining in the community, although disease manifestation was mild or asymptomatic. There were a few instances of vaccine-preventable diseases such as measles, mumps and rubella, among displaced participants in the shelter group as well as among those in the community group. These diseases likely occurred in unvaccinated participants or in those with weakened immune systems. The risk of amoebiasis seroconversion was higher in participants displaced to shelters who had hypertension and lower in participants with hyperlipidaemia. However, after adjusting for medical history, hypertension and hyperlipidaemia, multivariate logistic regression analysis showed that participants who stayed in shelters had a significantly higher risk for amoebiasis seroconversion than those in the community.

Recent data suggested a relationship between massive precipitation and climate-related diseases in Taiwan (ie, enterovirus infection, Japanese encephalitis, scrub typhus, dengue fever and, to some extent, meliodosis and leptospirosis).[@R24] However, the relationship between parasitic diseases and extreme rainfall remains unclear. Although Taiwan is considered a low-endemic area for amoebiasis,[@R20] and notification of cases to the Center for Disease Control (CDC) is mandatory, our present study showed that amoebiasis is not uncommon in Taiwan. The annual number of cases reported to the CDC in Taiwan ranged from only 146 to 264 between 2007 and 2011,[@R25] and studies suggested that there are many asymptomatic infections.[@R26]

Unlike outbreak reports, this longitudinal, paired serological epidemiological investigation relied on evidence of seroconversion to evaluate the incidence of infectious diseases among different populations of disaster-displaced persons. We found that prolonged shelter stay was associated with higher *E. histolytica antibody* seroconversion rates after Typhoon Morakot, even though those who showed seroconversion presented only mild symptoms or were asymptomatic. Our post-disaster serological data were consistent with a study of clinical laboratory methods of *E. histolytica* detection, which noted the asymptomatic nature of amoebiasis.[@R23] Our data strongly suggested that contaminated water supply in crowded shelters could play a major role in amoebiasis outbreaks seen after natural disasters. We suggest that a clean drinking water supply is crucial during post-disaster care and management, especially for displaced persons admitted to shelters. The presence of *E. histolytica* seroconversion among disaster-displaced people living in the community may be due to disaster-damaged public drinking water systems whereby some people living with their families in urban areas may also become infected.

Although an outbreak of leptospirosis was previously reported in Pingtung County (a non-mountainous area) after Typhoon Morakot, and melioidosis was also confirmed in areas of heavy precipitation after the typhoon,[@R12] there were no reports of leptospirosis outbreaks made to the CDC from the mountainous areas during our study period. This discrepancy suggested that rainfall levels and cumulative flooding may have a greater impact on leptospirosis and melioidosis outbreaks compared to typhoon strength.

Our data showed that a greater percentage of displaced persons admitted to shelters had family members who suffered a major trauma resulting in serious injury or death. On the other hand, the higher percentage of older displaced persons in the community group may be due to the fact that family members who originally resided in urban areas before Typhoon Morakot (not included in our cohort) were more likely to provide shelter to their elderly relatives. Different environmental circumstances as well as the different vaccine coverage rates among various age groups may explain the different seropositivity rates for mumps between younger adults in the two groups. However, among people aged ≥50 years in both groups, the baseline seropositivity rates for mumps were not different (74% in the shelter group vs 67.9% in the community group; p=0.150; data not shown).

Our present data showed some cases of seroconversion for vaccine-preventable diseases such as measles, mumps and, especially, rubella, among displaced persons during the study period. Although there were no significant differences in the seroconversion rates for these three diseases between the shelter and community groups, evidence of seroconversion among displaced persons suggested that there was a risk of outbreaks under these conditions. It is important to note that vaccine coverage rates are high in Taiwan, and there were no outbreaks during our study period, unlike the concurrent measles and rubella outbreaks in camps hosting Liberian displaced persons in Côte d\'Ivoire in 2004.[@R27] However, our data suggested that there was a risk of vaccine-preventable diseases after the disaster, regardless of the type of accommodations. Outbreaks of infectious diseases such as rubella in crowded shelters after natural disasters can be effectively prevented by extending vaccination programmes to populations who have a higher risk of post-disaster displacement and who are without antibody protection.

There is currently little evidence to provide guidance on whether staying in shelters is a more advantageous post-disaster accommodation policy in terms of preventing disease transmission among large numbers of displaced people, compared to remaining in the community. To our knowledge, this is the first study investigating differences in seroconversion rates between disaster-displaced persons staying in different types of accommodations. Our present data are consistent with previous results showing that effective post-disaster management and mitigation strategies are necessary to address the needs of flood-displaced persons, and to reduce the risk of communicable diseases,[@R4] [@R28] especially in vulnerable groups such as younger children and older adults with weaker immune systems.[@R29]

This study has several limitations. First, only 46.9% of the participants with *E. histolytica* IHA seroconversion were retrospectively interviewed. Bias in participants' ability to recall clinical symptoms or signs was also a limitation. Second, we did not directly examine the drinking water in the shelters; thus, a direct causal relationship between drinking water and *E. histolytica* seroconversion could not be established even though the risk of seroconversion was significantly higher in the shelter group compared to the community group. Another limitation was that although we recognise the importance of covering all infectious diseases in post-crisis situations, we could only investigate diseases based on local interests in this study. Finally, the sample size for this longitudinal study was relatively small. It is important to validate our current findings with a larger sample size.

In conclusion, after Typhoon Morakot, shelter stay was associated with higher risk for seroconversion of *E. histolytica.* Although displaced persons staying in shelters had higher seroconversion rates than those remaining in the community, manifestations were mild. Our results provide useful information for the pre-emptive preparation and response to relatively predictable typhoons and flooding, and suggested that a clean water supply is essential after a disaster, especially in relatively crowded shelters. Our finding of measles, mumps and rubella seroconversion among displaced participants, strongly suggested that prevention of large outbreaks of infectious diseases following natural disasters could be prevented by extending vaccination programmes to populations at higher risk for post-disaster displacement and to those with weakened immune systems.
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